Children’s Health in Dallas, Texas announced plans to use Proteus Digital Health’s ingestible medication sensors to track medication adherence in kids with liver and kidney transplants.
Medication adherence is a challenge for many patients for a variety of reasons — the complexity of medication regimens, costs, memory, and more all play into it. That problem is magnified by our (clinicians’) lack of awareness of it — we often just don’t know that our patients are, for whatever reason, not taking their medications.
Proteus’ ingestible medication sensor is compounded into a capsule with a medication. When it is swallowed, the sensor sends a signal to a body-worn patch as it dissolves in the stomach. That patch can then pass on that signal, indicating the medication was taken, to Proteus’ cloud-based system for monitoring and, more importantly, intervening if medications aren’t being taken as expected.
That’s particularly critical for transplant medications, where immunosuppressants mean the difference between graft survival (which often equals patient survival) and graft failure. In kids, especially as they hit their more rebellious years, that can be a particularly serious challenge.
Read Full Article – Source: Hospital to Pilot Ingestible Medication Sensors in Kids | Medpage Today